Pfizer (PFE) and Bristol-Myers Squibb (BMY) are bought for the same underlying reason: the search for new drugs to replace ...

Wells Fargo analyst Mohit Bansal lowered the firm’s price target on Bristol Myers (BMY) to $60 from $65 and keeps an Equal ...

Medicare beneficiaries using lower-priced negotiated drugs experienced out-of-pocket savings under the Medicare Drug Price ...

Millions of Americans who buy cheap drugs from Canada could soon lose access when a customs rule goes into effect later this ...

Ann Jackson, a Pittsford widow in the last stage of heart failure, wrote a letter to President Donald Trump asking him to ...

Bristol-Myers Squibb is reiterated as a buy, offering attractive valuation and a high 4.23% dividend yield. Click to read ...

A brief research report found that Medicare beneficiaries taking several commonly prescribed medications could see ...

Bristol-Myers Squibb is a Hold as replacing lost revenue from Eliquis and Opdivo presents a significant challenge. Click here ...

The number of medicine price concessions hit a new record high in September, the pharmacy negotiator has confirmed.

Track Cohance Lifesciences share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and ...

I recently retired and signed  up for a Medicare Advantage plan in 2026.  I take Xarelto 20 mg and through government ...